PMID- 10501191 OWN - NLM STAT- MEDLINE DCOM- 19991014 LR - 20190630 IS - 0022-3042 (Print) IS - 0022-3042 (Linking) VI - 73 IP - 4 DP - 1999 Oct TI - Brain-derived neurotrophic factor exerts opposing effects on beta2-adrenergic receptor according to depolarization status of cerebellar neurons. PG - 1467-76 AB - To investigate the molecular mechanisms underlying brain-derived neurotrophic factor (BDNF)-controlled synaptic plasticity, we studied beta2-adrenergic receptor (beta2-AR) expression in cultured cerebellar granule cells. We show that, depending on the state of depolarization, BDNF exerts opposite effects on beta2-AR expression. In neurons maintained in low K+ medium (5 mM K+) that will enter apoptosis, BDNF increases beta2-AR and beta2-AR transcripts. In contrast, in depolarized neurons (high K+ medium, 25 mM K+) BDNF represses beta2-AR expression. The use of reporter genes (driven by the beta2-AR promoter or restricted regulatory elements) revealed that BDNF exerts its opposite effects at the transcriptional level by recruiting a cyclic AMP response element (CRE) and the trans-acting factor CRE binding protein. These results provide the first evidence that a neurotrophin, e.g., BDNF, may exert an opposite effect on receptor expression and function (beta2-AR) according to the depolarization status of the neuron. Based on this finding, we propose that BDNF not only mediates neuronal survival, but is also involved in the modulation of the general sensitivity of the neuron to external signals, thus maintaining its optimal functional integration within the neuronal network. FAU - Gaiddon, C AU - Gaiddon C AD - UMR 7519 CNRS, Institut de Physiologie et de Chimie Biologique, Universite Louis Pasteur, Strasbourg, France. FAU - Larmet, Y AU - Larmet Y FAU - Trinh, E AU - Trinh E FAU - Boutillier, A L AU - Boutillier AL FAU - Sommer, B AU - Sommer B FAU - Loeffler, J P AU - Loeffler JP LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - J Neurochem JT - Journal of neurochemistry JID - 2985190R RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Cyclic AMP Response Element-Binding Protein) RN - 0 (Receptors, Adrenergic, beta-2) RN - 0 (Recombinant Fusion Proteins) RN - E0399OZS9N (Cyclic AMP) RN - L628TT009W (Isoproterenol) RN - RWP5GA015D (Potassium) SB - IM MH - Animals MH - Apoptosis/drug effects MH - Base Sequence MH - Brain-Derived Neurotrophic Factor/*pharmacology MH - Cell Survival/drug effects MH - Cells, Cultured MH - Cerebellum/cytology/*physiology MH - Cyclic AMP/metabolism MH - Cyclic AMP Response Element-Binding Protein/metabolism MH - Humans MH - Isoproterenol/pharmacology MH - Kinetics MH - Mutagenesis, Site-Directed MH - Neurons/cytology/drug effects/*physiology MH - Potassium/pharmacology MH - Promoter Regions, Genetic MH - Rats MH - Receptors, Adrenergic, beta-2/genetics/*physiology MH - Recombinant Fusion Proteins/biosynthesis MH - Reverse Transcriptase Polymerase Chain Reaction MH - Transcription, Genetic/*drug effects MH - Transfection EDAT- 1999/09/29 00:00 MHDA- 1999/09/29 00:01 CRDT- 1999/09/29 00:00 PHST- 1999/09/29 00:00 [pubmed] PHST- 1999/09/29 00:01 [medline] PHST- 1999/09/29 00:00 [entrez] AID - 10.1046/j.1471-4159.1999.0731467.x [doi] PST - ppublish SO - J Neurochem. 1999 Oct;73(4):1467-76. doi: 10.1046/j.1471-4159.1999.0731467.x.